NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

The efficacy of immunoradiotherapy consisting of radiation therapy and immune checkpoint blockade relies on effectively promoting the systemic antitumor immune response’s activation while simultaneously reducing local factors favoring immune suppression. We previously demonstrated that NBTXR3, a nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yun, Paris, Sébastien, Bertolet, Genevieve, Barsoumian, Hampartsoum B., Wang, Qi, Da Silva, Jordan, Patel, Nalini B., Nguyen, Nguyen, Doss, Denaha J., Huang, Ailing, Hsu, Ethan, Leyton, Claudia S. Kettlun, Voss, Tiffany A., Masrorpour, Fatemeh, Leuschner, Carola, Pietz, Jordan T., Puebla-Osorio, Nahum, Gandhi, Saumil, Nguyen, Quynh-Nhu, Wang, Jing, Cortez, Maria Angelica, Welsh, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669748/
https://www.ncbi.nlm.nih.gov/pubmed/36405757
http://dx.doi.org/10.3389/fimmu.2022.1022011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669748/
https://www.ncbi.nlm.nih.gov/pubmed/36405757
http://dx.doi.org/10.3389/fimmu.2022.1022011

Ejemplares similares